Literature DB >> 20143395

Allergies, obesity, other risk factors and survival from pancreatic cancer.

Sara H Olson1, Joanne F Chou, Emmy Ludwig, Eileen O'Reilly, Peter J Allen, William R Jarnagin, Sharon Bayuga, Jennifer Simon, Mithat Gonen, William R Reisacher, Robert C Kurtz.   

Abstract

Survival from pancreatic adenocarcinoma remains extremely poor, approximately 5% at 5 years. Risk factors include smoking, high body mass index (BMI), family history of pancreatic cancer, and long-standing diabetes; in contrast, allergies are associated with reduced risk. Little is known about associations between these factors and survival. We analyzed overall survival in relation to risk factors for 475 incident cases who took part in a hospital based case-control study. Analyses were conducted separately for those who did (160) and did not (315) undergo tumor resection. Kaplan-Meier methods were used to describe survival according to smoking, BMI, family history, diabetes, and presence of allergies. Cox proportional hazards models were used to adjust for covariates. There was no association with survival based on smoking, family history, or history of diabetes in either group. Among patients with resection, those with allergies showed nonstatistically significant longer survival, a median of 33.1 months (95% CI: 19.0-52.5) vs. 21.8 months (95% CI: 18.0-33.1), p = 0.25. The adjusted hazard ratio (HR) was 0.72 (95% CI: 0.43-1.23), p = 0.23. Among patients without resection, those with self-reported allergies survived significantly longer than those without allergies: 13.3 months (95% CI: 10.6-16.9) compared to 10.4 months (95% CI: 8.8-11.0), p = 0.04, with an adjusted HR of 0.68 (95% CI: 0.49-0.95), p = 0.02. Obesity was nonsignificantly associated with poorer survival, particularly in the resected group (HR = 1.62, 95% CI: 0.76-3.44). The mechanisms underlying the association between history of allergies and improved survival are unknown. These novel results need to be confirmed in other studies.

Entities:  

Mesh:

Year:  2010        PMID: 20143395     DOI: 10.1002/ijc.25240

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  A replication study and genome-wide scan of single-nucleotide polymorphisms associated with pancreatic cancer risk and overall survival.

Authors:  Jason A Willis; Sara H Olson; Irene Orlow; Semanti Mukherjee; Robert R McWilliams; Robert C Kurtz; Robert J Klein
Journal:  Clin Cancer Res       Date:  2012-06-04       Impact factor: 12.531

Review 2.  Obesity and pancreatic cancer: overview of epidemiologic evidence and biologic mechanisms.

Authors:  Paige M Bracci
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

Review 3.  Body mass index and outcomes from pancreatic resection: a review and meta-analysis.

Authors:  Andrew M Ramsey; Robert C Martin
Journal:  J Gastrointest Surg       Date:  2011-04-12       Impact factor: 3.452

4.  The inhibition of renin-angiotensin system in advanced pancreatic cancer: an exploratory analysis in 349 patients.

Authors:  Yousuke Nakai; Hiroyuki Isayama; Takashi Sasaki; Naminatsu Takahara; Kei Saito; Kazunaga Ishigaki; Tsuyoshi Hamada; Suguru Mizuno; Koji Miyabayashi; Keisuke Yamamoto; Dai Mohri; Hirofumi Kogure; Natsuyo Yamamoto; Hideaki Ijichi; Keisuke Tateishi; Minoru Tada; Kazuhiko Koike
Journal:  J Cancer Res Clin Oncol       Date:  2014-11-15       Impact factor: 4.553

Review 5.  Molecular biology of pancreatic cancer.

Authors:  Miroslav Zavoral; Petra Minarikova; Filip Zavada; Cyril Salek; Marek Minarik
Journal:  World J Gastroenterol       Date:  2011-06-28       Impact factor: 5.742

Review 6.  Premorbid Obesity and Mortality in Patients With Pancreatic Cancer: A Systematic Review and Meta-analysis.

Authors:  Kaustav Majumder; Arjun Gupta; Nivedita Arora; Preet Paul Singh; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2015-10-14       Impact factor: 11.382

7.  Survival among patients with pancreatic cancer and long-standing or recent-onset diabetes mellitus.

Authors:  Chen Yuan; Douglas A Rubinson; Zhi Rong Qian; Chen Wu; Peter Kraft; Ying Bao; Shuji Ogino; Kimmie Ng; Thomas E Clancy; Richard S Swanson; Megan J Gorman; Lauren K Brais; Tingting Li; Meir J Stampfer; Frank B Hu; Edward L Giovannucci; Matthew H Kulke; Charles S Fuchs; Brian M Wolpin
Journal:  J Clin Oncol       Date:  2014-11-17       Impact factor: 44.544

8.  Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma.

Authors:  Rong Lin; Chao-Qun Han; Wei-Jun Wang; Jun Liu; Wei Qian; Zhen Ding; Xiao-Hua Hou
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-08-08

9.  Impact of body mass index on complications following pancreatectomy: Ten-year experience at National Cancer Center in China.

Authors:  Ying-Tai Chen; Qian Deng; Xu Che; Jian-Wei Zhang; Yu-Heng Chen; Dong-Bin Zhao; Yan-Tao Tian; Ya-Wei Zhang; Cheng-Feng Wang
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

10.  Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey.

Authors:  Chao-Feng Chang; Yu-Chen Tseng; Hsin-Hung Huang; Yu-Lueng Shih; Tsai-Yuan Hsieh; Hsuan-Hwai Lin
Journal:  Intern Emerg Med       Date:  2017-12-12       Impact factor: 3.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.